Literature DB >> 9186641

The roles of B cells in MRL/lpr murine lupus.

O Chan1, M P Madaio, M J Shlomchik.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9186641     DOI： 10.1111/j.1749-6632.1997.tb52046.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  30 in total

Review 1.  B cells in glomerulonephritis: focus on lupus nephritis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

2.  Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.

Authors:  Lena Schiffer; Ramalingam Bethunaickan; Meera Ramanujam; Weiqing Huang; Mario Schiffer; Haiou Tao; Michael P Madaio; Michael M Madaio; Erwin P Bottinger; Anne Davidson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

3.  Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice.

Authors:  Ramalingam Bethunaickan; Celine C Berthier; Weijia Zhang; Ridvan Eksi; Hong-Dong Li; Yuanfang Guan; Matthias Kretzler; Anne Davidson
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

4.  iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling.

Authors:  Xiaoping Qing; Yurii Chinenov; Patricia Redecha; Michael Madaio; Joris Jth Roelofs; Gregory Farber; Priya D Issuree; Laura Donlin; David R Mcllwain; Tak W Mak; Carl P Blobel; Jane E Salmon
Journal:  J Clin Invest       Date:  2018-03-05       Impact factor: 14.808

5.  Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.

Authors:  Chelsea Corradetti; Neelakshi R Jog; Matteo Cesaroni; Michael Madaio; Roberto Caricchio
Journal:  J Immunol       Date:  2017-12-13       Impact factor: 5.422

6.  The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy.

Authors:  Lee A Honigberg; Ashley M Smith; Mint Sirisawad; Erik Verner; David Loury; Betty Chang; Shyr Li; Zhengying Pan; Douglas H Thamm; Richard A Miller; Joseph J Buggy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

7.  Caspase-activated DNase is required for maintenance of tolerance to lupus nuclear autoantigens.

Authors:  Neelakshi R Jog; Lorenza Frisoni; Qin Shi; Marc Monestier; Sairy Hernandez; Joe Craft; Eline T Luning Prak; Roberto Caricchio
Journal:  Arthritis Rheum       Date:  2011-11-29

8.  False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies.

Authors:  H S Jethwa; P H Nachman; R J Falk; J C Jennette
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 9.  Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.

Authors:  Christopher M Reilly; Gary S Gilkeson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

10.  Similarities and differences between selective and nonselective BAFF blockade in murine SLE.

Authors:  Meera Ramanujam; Xiaobo Wang; Weiqing Huang; Zheng Liu; Lena Schiffer; Haiou Tao; Daniel Frank; Jeffrey Rice; Betty Diamond; Karl O A Yu; Steven Porcelli; Anne Davidson
Journal:  J Clin Invest       Date:  2006-02-16       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.